JP2003512426A5 - - Google Patents

Download PDF

Info

Publication number
JP2003512426A5
JP2003512426A5 JP2001532759A JP2001532759A JP2003512426A5 JP 2003512426 A5 JP2003512426 A5 JP 2003512426A5 JP 2001532759 A JP2001532759 A JP 2001532759A JP 2001532759 A JP2001532759 A JP 2001532759A JP 2003512426 A5 JP2003512426 A5 JP 2003512426A5
Authority
JP
Japan
Prior art keywords
use according
compound
salt
alkyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001532759A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003512426A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/029618 external-priority patent/WO2001030339A1/en
Publication of JP2003512426A publication Critical patent/JP2003512426A/ja
Publication of JP2003512426A5 publication Critical patent/JP2003512426A5/ja
Pending legal-status Critical Current

Links

JP2001532759A 1999-10-27 2000-10-27 双極性気分障害における躁病の治療のための1−アミノインダンの使用。 Pending JP2003512426A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16181799P 1999-10-27 1999-10-27
US60/161,817 1999-10-27
PCT/US2000/029618 WO2001030339A1 (en) 1999-10-27 2000-10-27 Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder

Publications (2)

Publication Number Publication Date
JP2003512426A JP2003512426A (ja) 2003-04-02
JP2003512426A5 true JP2003512426A5 (enExample) 2007-12-27

Family

ID=22582876

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001532759A Pending JP2003512426A (ja) 1999-10-27 2000-10-27 双極性気分障害における躁病の治療のための1−アミノインダンの使用。

Country Status (9)

Country Link
US (1) US6492426B1 (enExample)
EP (1) EP1242066B1 (enExample)
JP (1) JP2003512426A (enExample)
AT (1) ATE331508T1 (enExample)
AU (1) AU775885B2 (enExample)
CA (1) CA2387394C (enExample)
DE (1) DE60029131T2 (enExample)
IL (2) IL149308A0 (enExample)
WO (1) WO2001030339A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140090996A (ko) * 2011-10-10 2014-07-18 테바 파마슈티컬 인더스트리즈 리미티드 R(+)-n-폼일-프로파길-아미노인단
US9181026B2 (en) 2013-10-03 2015-11-10 Custom Chemical Solutions, LLC Containment berm with internal “L” braces
WO2024196698A2 (en) * 2023-03-17 2024-09-26 Curadh Mtr Compounds and constructs useful for targeting fibroblast activation protein

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB852735A (en) 1956-04-13 1960-11-02 Schering Ag Manufacture of 1-aminoindanes
US3637740A (en) * 1969-04-21 1972-01-25 Pfizer Aminobenzocycloalkane compounds
BE786748A (fr) * 1971-07-26 1973-01-26 Basf Ag 1-aminomethyl-indanes-n-substitues
US4096173A (en) * 1977-03-28 1978-06-20 Eli Lilly And Company Chlorinated 1-aminoindane N-methyl transferase inhibitors
JPS5824433A (ja) * 1981-08-06 1983-02-14 Takehiro Mokuzai Kogyo Kk 繊維材成型品の表面化粧方法
SE464194B (sv) 1983-03-04 1991-03-18 Otsuka Pharma Co Ltd Indanderivat, foerfarande foer framstaellning daerav samt farmaceutiska kompositioner
EP0173331B1 (en) 1984-08-31 1991-08-14 Otsuka Pharmaceutical Co., Ltd. 2,3-dihydro-1h-indene derivatives, a process for preparing them and pharmaceutical compositions containing same
US5242919A (en) 1984-08-31 1993-09-07 Otsuka Pharmaceutical Co., Ltd. 2,3-dihydro-1H-indene derivatives
JPS6169747A (ja) 1984-08-31 1986-04-10 Otsuka Pharmaceut Co Ltd 2,3―ジヒドロ―1h―インデン誘導体及びその製造法
US4882339A (en) 1987-07-10 1989-11-21 Ciba-Geigy Corporation 4-Amino-substituted 1,2-dihydroxynaphthalene derivatives useful in inhibiting 5-lipoxygenase activity in mammals
US5744500A (en) 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
IL92952A (en) 1990-01-03 1994-06-24 Teva Pharma R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them
IL99759A (en) 1991-10-16 1997-06-10 Teva Pharma Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
US5344836A (en) 1991-11-11 1994-09-06 Ono Pharmaceutical Co., Ltd. Fused benzeneoxyacetic acid derivatives
CH683996A5 (fr) 1992-03-05 1994-06-30 Symphar Sa Dérivés aminophosphonates substitués, leur procédé de préparation et compositions pharmaceutiques les contenant.
KR100238346B1 (ko) 1993-04-07 2000-03-02 오쓰까 아끼히꼬 피페리딘 유도체를 유효성분으로 하는 말초혈관확장제
IL111240A (en) 1993-10-18 2001-10-31 Teva Pharma Salts of r(+) - enantiomers of n- propargyl-1-aminoindan and pharmaceutical compositions comprising them
AU1867095A (en) 1994-01-10 1995-08-01 Technion Research & Development Foundation Ltd. 1-aminoindan derivatives and compositions thereof
US5877218A (en) 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
CH690264A5 (fr) 1995-06-30 2000-06-30 Symphar Sa Dérivés aminophosphonates substitués, leur procédé de préparation et leur utilisation pour la préparation de compositions pharmaceutiques.
US5646188A (en) 1995-07-05 1997-07-08 Teva Pharmaceutical Industries, Ltd. Polyamine derivatives of 1-aminoindan
IL115357A (en) 1995-09-20 2000-01-31 Teva Pharma Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols
US5887218A (en) 1996-06-10 1999-03-23 Ricoh Co., Ltd. Color image forming apparatus having toner and transfer sheet bearing members and image forming method thereof
DE69732984T2 (de) 1996-12-18 2006-02-16 Teva Pharmaceutical Industries Ltd. Aminoindanderivate
US6251938B1 (en) 1996-12-18 2001-06-26 Teva Pharmaceutical Industries, Ltd., Phenylethylamine derivatives
WO1998055447A1 (en) 1997-06-05 1998-12-10 Venantius Limited 3-aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them
US5887221A (en) 1997-10-20 1999-03-23 Xerox Corporation Signature sensing for optimum toner control with donor roll
US6227886B1 (en) 1999-04-16 2001-05-08 Avaya Technology Corp. Snag-resistant patchcord plug latch and cover

Similar Documents

Publication Publication Date Title
JP2003531118A5 (enExample)
JP2005515964A5 (enExample)
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
JP2006506425A5 (enExample)
JP2004524316A5 (enExample)
JP2008509187A5 (enExample)
JP2004500426A5 (enExample)
JP2005519908A5 (enExample)
JP2005535592A5 (enExample)
JP2002520316A5 (enExample)
JP2005533860A5 (enExample)
JP2002502836A5 (enExample)
JP2003503449A5 (enExample)
JP2002527414A5 (enExample)
TW201912153A (zh) 用於治療b型肝炎的化合物、醫藥組合物及方法
JP2001520994A5 (enExample)
JP2003512426A5 (enExample)
JP2011068661A (ja) 洞房結節If電流阻害剤およびカルシウム阻害剤の新規な組み合わせならびにそれを含む医薬組成物
JP2004533415A5 (enExample)
JP5744003B2 (ja) 抗ウイルス化合物を調製する方法
JP2008521934A5 (enExample)
JP2005513036A5 (enExample)
JP2001518468A5 (enExample)
JP2006510659A5 (enExample)
JP2002503724A5 (enExample)